AlphaStar Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

AlphaStar Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$329K	Buy	2,077 +19	+0.9%	+$2.57K	0.02%	221
2026 Q1	$263K	Sell	2,058 -13	-0.6%	-$1.62K	0.02%	206
2025 Q4	$253K	Sell	2,071 -239	-10%	-$27.4K	0.02%	218
2025 Q3	$231K	Sell	2,310 -530	-19%	-$47.7K	0.02%	179
2025 Q2	$235K	Sell	2,840 -87	-3%	-$6.94K	0.02%	327
2025 Q1	$237K	Sell	2,927 -54	-2%	-$4.83K	0.02%	166
2024 Q4	$268K	Sell	2,981 -206	-6%	-$20K	0.03%	173
2024 Q3	$315K	Buy	+3,187	New	+$313K	0.03%	302
2021 Q1	–	Sell	-9,258	Closed	-$1.41M	–	243
2020 Q4	$1.41M	Sell	9,258 -1,798	-16%	-$230K	0.24%	82
2020 Q3	$1.31M	Buy	+11,056	New	+$1.24M	0.26%	81

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

AlphaStar Capital Management's XBI Position: Q2 2026 in Review

AlphaStar Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.92% in Q2 2026, buying an estimated $2.57K and bringing the position to 2,077 shares worth $329K. The position accounts for 0.02% of the portfolio, ranked #221.

AlphaStar Capital Management first reported a position in XBI in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.41M in Q4 2020. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

AlphaStar Capital Management held 2,077 shares of State Street SPDR S&P Biotech ETF worth $329K as of Q2 2026.
AlphaStar Capital Management bought 19 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.57K.
State Street SPDR S&P Biotech ETF made up 0.02% of AlphaStar Capital Management's portfolio in Q2 2026, its #221 holding.
AlphaStar Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 10 quarters since.
AlphaStar Capital Management's State Street SPDR S&P Biotech ETF position peaked at $1.41M in Q4 2020.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on AlphaStar Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.